Kynurenic acid (sodium)
Kynurenic acid sodium, an endogenous tryptophan metabolite, is a broad-spectrum antagonist targeting NMDA, glutamate, α7 nicotinic acetylcholine receptor. Kynurenic acid sodium is also an agonist of GPR35/CXCR8.
Product Specifications
CAS Number
2439-02-3
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
Apoptosis; CXCR; Endogenous Metabolite; GPR35 ; iGluR
Type
Reference compound
Related Pathways
Apoptosis; GPCR/G Protein; Immunology/Inflammation; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease; Endocrinology
Assay Protocol
https://www.medchemexpress.com/Kynurenic_acid_sodium.html
Purity
99.82
Solubility
DMSO : 50 mg/mL (ultrasonic) |H2O : < 0.1 mg/mL
Smiles
O=C(C1=NC2=CC=CC=C2C(O)=C1)O[Na]
Molecular Formula
C10H6NNaO3
Molecular Weight
211.15
Precautions
H302, H315, H319
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Human Endogenous Metabolite; NMDA Receptor
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Fibronectin (HFN7.1), CF568 conjugate, 0.1mg/mL
MUC18 / Mucin 18 / CD146 (OJ79c), CF647 conjugate, 0.1mg/mL
Von Willebrand Factor (3E2D10), CF568 conjugate, 0.1mg/mL
